Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Total Current Liabilities (2024 - 2026)

Updated

Revium Rx (RVRC) reported Total Current Liabilities of $971,000 for Q2 2026.

Analysis

Revium Rx (RVRC) Total Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Revium Rx posted Total Current Liabilities of $799,000, up 38.7% from FY2024.

  • By year, Total Current Liabilities came in at $576,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,170.46 Bn 1,139.04 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 648.38 Bn 568.24 Bn 17.30 Bn 55.46 Bn
3 AbbVie 504.43 Bn 477.54 Bn 12.70 Bn 41.64 Bn
4 Merck 367.73 Bn 322.11 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 303.35 Bn 267.34 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 268.20 Bn 241.88 Bn 12.86 Bn 31.55 Bn
7 Amgen 242.55 Bn 197.95 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 194.80 Bn 169.00 Bn 6.22 Bn 11.02 Bn
9 Pfizer 173.31 Bn 119.95 Bn 10.94 Bn 32.65 Bn
10 Revium Rx 86.84 Mn 86.00 Mn - 971,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 971,000.00
Dec 31, 2025 799,000.00
Dec 31, 2024 576,000.00
API Access

Revium Rx Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=RVRC&period=max&api_key=YOUR_API_KEY